Clinical Trial Update: A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) [Phase 1]

View source ↗

Summary

A Phase I, multi-tumor study evaluating Cardonizumab in combination with pulsed low-dose rate external irradiation (PLDR) as first-line therapy; the trial is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Esophageal Cancer
• Lung Cancer

Drugs mentioned

• Cardonizumab (Cardonizumab)

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Lung Cancer, Esophageal Cancer | Phase 1 | Status: RECRUITING